Bayer Looks to Lion Again in $25M Deal to Link Bio, Cheminformatics; Tripos to Help | GenomeWeb

Building on the existing $100 million, five-year bioinformatics deal that Bayer and Lion Bioscience entered into last year, the two companies, along with Tripos of St. Louis, have penned a $25 million agreement to integrate bioinformatics and cheminformatics at the German life sciences company.

The companies expect the technology platform to speed Bayer’s drug discovery and agricultural chemical research.

Bayer officials were unavailable for immediate comment.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.